Article
Analytical and Potential Clinical Performance of Oncomine Myeloid Research Assay for Myeloid Neoplasms.
Molecular diagnosis & therapy - 1 Oct 2020
Park Joonhong, Kim Hoon Seok, Lee Jong-Mi, Jung Jin, Kang Dain, Choi Hayoung, Lee Gun Dong, Son Jungok, Park Silvia, Cho Byung-Sik, Kim Hee-Je, Kim Seongkoo, Lee Jae Wook, Chung Nack-Gyun, Cho Bin, Zhang Hua, Khazanov Nickolay A, Choi Jongpill, Jung Jae-Won, Kim Yonggoo, Kim Myungshin
Abstract excerpt
INTRODUCTION: Next-generation sequencing (NGS) panels have recently been introduced to efficiently detect genetic variations in hematologic malignancies. OBJECTIVES: Our aim was to evaluate the performance of the commercialized Oncomine™ myeloid research assay (OMA) for myeloid neoplasms. METHODS: Certified reference materials and clinical research samples were used, including 60 genomic DNA and 56 RNA samples....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
